Complementary Medicines Australia
Complementary Medicines Australia is the peak industry body representing Australia's complementary medicines supply chain — including manufacturers, raw material suppliers, researchers and retailers — providing regulatory advocacy, industry events, training and international trade programs to its members.
- Company typePrivate
- Founded-
- HeadquartersCanberra, Australia
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Complementary Medicines Australia does
Complementary Medicines Australia (CMA), legally Complementary Medicines Australia Limited (ABN 49 169 036 088), is the peak industry body representing the complementary medicines supply chain in Australia. Headquartered in Mawson, Australian Capital Territory, the organisation serves manufacturers, raw material suppliers, researchers, retailers, importers, exporters, wholesalers, consultants and direct/multi-level marketers of complementary medicines, vitamins and dietary supplements. Its core value proposition is regulatory advocacy and industry representation, with staff embedded across all Therapeutic Goods Administration (TGA) policy and technical working groups to influence regulation, secure market exclusivity outcomes for new ingredients, and provide members with technical updates and compliance resources.
CMA operates a membership-based, event-anchored business model. Revenue is generated through three principal streams: recurring annual membership subscriptions (the core GTM motion), event registration fees (members receive discounted rates across the Annual Conference, Innovation Day, Biotics Day and training sessions), and exhibition and sponsorship revenue from flagship events. The flagship Annual Conference attracts over 300 delegates and 30+ exhibitors in Sydney each November, Innovation Day draws 220+ delegates and 20+ exhibitors in May, and the inaugural CMA Biotics Day was launched in June 2026 in Melbourne. Membership benefits include regulatory templates, access to the IMgateway medical resource tool, member-only training and discounts, and inclusion in industry awards.
Internationally, CMA runs a trade-development programme including the Australian Pavilion at Healthplex Expo in Shanghai (hosted for five consecutive years), trade delegations to China, and a decade-long partnership with the China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE). Austrade-faciliated business matching and regulatory training are delivered under the Trade Diversification Network, which CMA joined in January 2026. The organisation also publishes the annual Industry Snapshot and Regulatory Outcomes Report as authoritative data products. Operationally, CMA runs a lean 11-person team led by CEO John O'Doherty (appointed July 2023), and is governed by a Board of Directors with member-elected representation.
Complementary Medicines Australia firmographics
Firmographics- Name
- Complementary Medicines Australia
- Legal name
- Complementary Medicines Australia Limited
- Website
- https://cmaustralia.org.au
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Complementary Medicines Australia is the peak industry body representing Australia's complementary medicines supply chain — including manufacturers, raw material suppliers, researchers and retailers — providing regulatory advocacy, industry events, training and international trade programs to its members.
- Ownership category
- akta.pro rank
Complementary Medicines Australia industry classification
Industry- Product category
- Industry Trade Association
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Retail & Community Pharmacies (Chain/Independent) (HLAFALAA)
- akta.pro secondary industry
- Medical Foods Manufacturing (Disease-Specific, Clinically Supervised) (AFAKAJAC)
Keywords
Where Complementary Medicines Australia is headquartered
LocationHeadquarters
- HQ city
- Canberra
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
Complementary Medicines Australia business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Membership Fees: CMA generates revenue through annual membership fees from companies across the complementary medicines supply chain including manufacturers, raw material suppliers, researchers, retailers, importers, exporters, wholesalers, consultants, and direct/multi-level marketers.
- Event Registrations: Revenue generated from event registrations for industry conferences, training sessions, and networking events. Members receive discounted rates while non-members pay standard registration fees.
- Exhibition and Sponsorship: Revenue from exhibitor fees and event sponsorship opportunities at flagship events such as the Annual Conference, Innovation Day, and specialized events like CMA Biotics Day.
Go-to-market motion3 records
Distribution channels1 record
Marketing channels8 records
Complementary Medicines Australia product offering
Product offeringCore offering
Complementary Medicines Australia is a peak industry body that represents manufacturers, raw material suppliers, researchers, and retailers across the complementary medicines supply chain. Its core services are membership-based advocacy to government and regulators (notably the TGA), industry events including the Annual Conference, Innovation Day, and Biotics Day, international trade programs through the Australian Pavilion at Healthplex Expo in Shanghai, regulatory affairs support, training, and industry research publications.
Product overview
Complementary Medicines Australia (CMA) is an industry peak body, not a technology product company. CMA operates as a membership-based industry association offering a unified service portfolio centered on advocacy, events, and member support. The core offerings include: membership services providing access to advocacy, news, resources, and IMgateway; flagship annual events (Annual Conference & Industry Awards, Innovation Day, Biotics Day); international trade programs (Australian Pavilion at Healthplex Expo, trade delegations); and industry publications (Industry Snapshot, Regulatory Outcomes Report). There is no platform-plus-modules architecture; rather, CMA provides integrated services under its unified membership model.
Differentiator
Problem solved
Functional benefit
Products and services
- CMA Membership Services Annual membership program for businesses across the complementary medicines supply chain providing advocacy, regulatory updates, events access, networking, template resources, and complimentary IMgateway medical resource tool access.
- CMA Annual Conference and Industry Awards Flagship annual conference held each November in Sydney bringing together over 300 delegates and 30+ exhibitors, featuring keynotes, expert panels, breakout sessions, and the CMA Industry Awards Gala Dinner.
- CMA Innovation Day Annual one-day event held in May in Sydney dedicated to scientific breakthroughs, novel ingredients, consumer behaviour changes, and regulatory innovation in complementary medicines, attracting 220+ delegates and 20+ exhibitors.
- CMA Biotics Day Inaugural focused one-day industry event exploring prebiotics, probiotics, and postbiotics, highlighting advances in scientific research, product innovation, ingredient development, and regulatory frameworks shaping the microbiome health sector.
- Australian Pavilion at Healthplex Expo Annual Australian national pavilion at Healthplex Expo in Shanghai providing CMA members a platform to promote products, manufacturing capabilities, and expertise to buyers, distributors, and industry partners in China and broader Asia-Pacific.
- Member Training and Professional Development Member-focused education including webinars on topics such as modern slavery and competition law, in-person training days, introductory seminars for those new to the industry, and regulatory and compliance sessions.
- CMA Industry Snapshot Annual flagship report capturing the scale, performance, and direction of Australia's complementary medicines sector including data and trends across product categories, exports, consumer demand, and innovation.
- CMA Regulatory Outcomes Report Annual detailed summary of regulatory advocacy, engagement, and outcomes delivered on behalf of members, supporting a strong, sustainable complementary medicines industry through proportionate, risk-based regulation.
- Trade Delegations and International Development Export and trade programs including trade delegations to international markets such as China, business matching with prospective partners facilitated by Austrade, and engagement with international regulatory bodies through partnerships such as CCCMHPIE.
Companies that use Complementary Medicines Australia
Customer profileNamed customers7 records
Segments5 records
Ideal customer profiles4 records
Complementary Medicines Australia technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Complementary Medicines Australia partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered minor and core.
- Life-Space ProbioticsminorMajor sponsor and exhibitor of CMA Biotics Day 2026 event at Park Hyatt Melbourne, focused on prebiotics, probiotics, and postbiotics.
- IFF Health SciencesminorExhibitor at CMA Biotics Day 2026, showcasing ingredient development and innovation in the microbiome health sector.
- EurofinsminorExhibitor at CMA Biotics Day 2026, providing testing and quality assurance services.
- Sacco SystemminorExhibitor at CMA Biotics Day 2026, showcasing probiotic and biotics ingredients.
- MorinagaminorExhibitor at CMA Biotics Day 2026, featuring Japanese probiotic expertise and ingredient solutions.
- ADMminorExhibitor at CMA Biotics Day 2026, showcasing ingredient development capabilities in health and nutrition.
- China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE)core10-year partnership anniversary marked at Healthplex 2026. Joint organization of the Australian Pavilion at Healthplex Expo and collaboration in strengthening trade relationships supporting Australia's complementary medicines industry in China.
- International Probiotics AssociationcoreHistoric partnership agreement signed between the International Probiotics Association and Complementary Medicines Australia, reflecting collaboration in the probiotics and microbiome health sector.
- Australian Trade and Investment Commission (Austrade)coreSupport under the Trade Diversification Network (TDN) program. Austrade facilitates targeted business matching meetings between Australian exhibitors and prospective Chinese partners, and delivers seminars on China's regulatory requirements such as Decree 280 regulations.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Complementary Medicines Australia competitors and assessment
Company assessmentRegional players
- Health Products Association of New Zealand: New Zealand industry association representing natural health products and complementary medicines manufacturers and suppliers. Closely comparable to CMA in mandate, membership composition, and regulatory advocacy (Medsafe), operating in the trans-Tasman market.
- Food Supplements Europe: European industry association representing food supplement manufacturers and marketers. Comparable to CMA in regulatory advocacy and member services, focused on EU food supplement regulation — providing an international benchmark for CMA's category representation model.
- Direct Selling Australia: Australian industry association for the direct selling sector. Functionally and structurally analogous to CMA (membership trade body, advocacy, events), with prior employment overlap with CMA staff (Head of Member Engagement Paul Seitz).
Direct peers
- American Herbal Products Association: US national trade association for the herbal products industry, focused on regulatory and quality standards for botanicals. Directly comparable to CMA's herbal and complementary medicine manufacturer membership base and regulatory representation role.
- Natural Products Association: The leading US trade association representing the natural products industry, including dietary supplements and complementary health products. Operates a similar member-funded advocacy, events, and regulatory engagement model as CMA, with a comparable peak-body mandate.
- International Alliance of Dietary/Food Supplement Associations: Global federation of national dietary supplement and complementary health product associations. CMA is a natural peer/member of this global umbrella; comparable in representing industry trade associations with a focus on international regulatory alignment and information sharing.
- Council for Responsible Nutrition: US-based trade association for the dietary supplement and functional food industry. Closely parallel to CMA in serving manufacturers and ingredient suppliers, with a strong regulatory advocacy focus at FDA and comparable to CMA's TGA engagement.
- Australian Self-Medication Industry: The peak Australian industry body for the non-prescription medicines and consumer healthcare products sector. Operates the same membership-advocacy-events model as CMA in Australia, covering adjacent OTC and complementary categories with shared regulatory engagement with TGA.
Emerging players
- Probiotics Association of Australia: A specialized industry body representing probiotics stakeholders in Australia. Operates within CMA's expanded scope following the launch of CMA Biotics Day 2026, making it a peer or adjacent organization within the microbiome health sub-segment CMA has entered.
Broad incumbents
- Consumer Healthcare Products Association: Major US trade association for the consumer healthcare industry including OTC medicines, dietary supplements, and personal care. Broader and larger than CMA, but operates an analogous advocacy and member services model across overlapping complementary health categories.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Complementary Medicines Australia social profiles
Digital presenceComplementary Medicines Australia financial estimates
Financial estimateRevenue estimate
Valuation estimate
Complementary Medicines Australia leadership team
Management profileNumber of profiles
Profiles11 records
Complementary Medicines Australia funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Complementary Medicines Australia M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Complementary Medicines Australia
What does Complementary Medicines Australia do?
Complementary Medicines Australia is a peak industry body that represents manufacturers, raw material suppliers, researchers, and retailers across the complementary medicines supply chain. Its core services are membership-based advocacy to government and regulators (notably the TGA), industry events including the Annual Conference, Innovation Day, and Biotics Day, international trade programs through the Australian Pavilion at Healthplex Expo in Shanghai, regulatory affairs support, training, and industry research publications.
Is Complementary Medicines Australia a public or private company?
Complementary Medicines Australia is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Complementary Medicines Australia founded?
Complementary Medicines Australia was founded in -1. It employs 11 to 50 people.
Where is Complementary Medicines Australia based?
Complementary Medicines Australia is headquartered in Canberra, Australia, in the Oceania region.
How does Complementary Medicines Australia make money?
Three revenue lines are on record. Membership Fees are the primary driver. The others are event Registrations and exhibition and Sponsorship.
Who are Complementary Medicines Australia's main competitors?
Regional players on record are Health Products Association of New Zealand, Food Supplements Europe and Direct Selling Australia. Direct peers are American Herbal Products Association, Natural Products Association, International Alliance of Dietary/Food Supplement Associations, Council for Responsible Nutrition and Australian Self-Medication Industry. Probiotics Association of Australia is listed as an emerging player. Consumer Healthcare Products Association is listed as a broad incumbent.
Does Complementary Medicines Australia have an API?
No public API is recorded for Complementary Medicines Australia.
What industry is Complementary Medicines Australia in?
Complementary Medicines Australia's product category is Industry Trade Association. Its primary akta.pro industry code is HLAFALAA, Retail & Community Pharmacies (Chain/Independent), with a secondary code of AFAKAJAC, Medical Foods Manufacturing (Disease-Specific, Clinically Supervised). Its NAICS code is 325412 and its SIC code is 5122.